Navkirat Kahlon, M.D.
Hematology & Oncology Physician · Boston, MA
Navkirat Kahlon, M.D. is a hematology & oncology physician with a practice address in Boston, Massachusetts, and NPI 1467803056, issued on Jun 25, 2016. Check the license (Massachusetts PHY101446, as entered in NPPES) on the Massachusetts Board of Registration in Medicine; the Medicare figures below come from public CMS files.
- Name
- Navkirat Kahlon
- Credential
- M.D.
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License numbers
- PHY101446 MA
22237 NH
Self-reported in NPPES; status is on the state search - Practice location
- 55 Fruit St, Boston, MA 02114
- Phone
- (617) 726-2000
- Enumerated
- Jun 25, 2016
- Record last updated
- Sep 23, 2024
- Medicare enrollment
- Enrolled (PECOS I20220706000202); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 461 in Massachusetts → Look up another NPI →
Also registered at 55 Fruit St
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Affan Aamir, MD, PHARMD, RPHStudent in an Organized Health Care Education/Training Program1821890377
- Matthew AbadirAnesthesiology Physician1699120550
- Taimur AbbasiInternal Medicine Physician1841673522
- Megan Abbott, MDAnesthesiology Physician1730839333
- Moustafa AbdallaStudent in an Organized Health Care Education/Training Program1952046062
- Shadi Abdar Esfahani, MD, MPHDiagnostic Radiology Physician1497137590
Verify Navkirat Kahlon in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMassachusetts Board of Registration in Medicine
Search for license PHY101446Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
About as many Medicare Part D claims as the average hematology & oncology physician in 2024
879 Medicare Part D claims for 151 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 27% of claims. 12 claims were for opioids.
Most prescribed
- Eliquis87 claims
- Letrozole76 claims
- Prednisone48 claims
- Ondansetron Hcl36 claims
- Abiraterone Acetate34 claims
- Prochlorperazine Maleate34 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Bills Medicare through one group practice
- Wentworth Douglass Physician CorporationDover, NH
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Navkirat Kahlon among 461 hematology & oncology physician records in Massachusetts
Navkirat Kahlon, M.D. is one of 461 hematology & oncology physician records with a practice address in Massachusetts. 75% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2016, is newer than 88% of them.
- NPI issued2016 · 88% of these records are older, 9% newer
- In a Medicare fileYes · 75% of these records are
- In the CMS Doctors and Clinicians fileYes · 66% of these records are
- Graduated2012 · median 2004 among the 303 with a school on file
- Record last updated2024 · 62% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Massachusetts practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Massachusetts
There are 461 hematology & oncology physician records in Massachusetts.
All 461 in Massachusetts → Every provider in Boston → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Vassiliki Boussiotis, MD PHDBoston, MA 021141861474215
- Marcia Browne, MDBoston, MA 021141639146210
- George Canellos, MDBoston, MA 021141114908027
- Yi-Bin Chen, MDBoston, MA 021141356332639
- John ClarkBoston, MA 021141871550244
- Lauren Dias, MDBoston, MA 021141215928346
- Kira Gritsman, MDBoston, MA 021141174598148
- David HarmonBoston, MA 021141851358352
Common questions
What is Navkirat Kahlon, M.D.'s NPI number?
Navkirat Kahlon, M.D.'s National Provider Identifier (NPI) is 1467803056, issued on Jun 25, 2016. An NPI identifies a provider in billing; it is not a license.
Where is Navkirat Kahlon, M.D. located?
The NPPES record lists a practice address at 55 Fruit St, Boston, MA, 02114. Phone: (617) 726-2000. Providers update this record themselves, so call before visiting.
How can I verify Navkirat Kahlon, M.D.'s license?
NPPES lists Massachusetts license number PHY101446, as entered by the provider. Search the Massachusetts Board of Registration in Medicine at https://findmydoctor.mass.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Navkirat Kahlon, M.D. prescribe under Medicare Part D?
In 2024, Navkirat Kahlon, M.D. had 879 Medicare Part D claims for 151 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.